You are here

FDA warns researchers on claims of drug to detect brain disease

New York

THE developers of a new drug aimed at diagnosing chronic traumatic encephalopathy, the degenerative brain disease linked to repeated head trauma, are under scrutiny by the US Food and Drug Administration.

In February, the FDA's Office of Prescription Drug Promotion sent a

Market voices on:

Powered by GET.comGetCom